Clinical trial

ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of…

NCT01827904 · InSightec, Industry · Completed

Key facts

NCT number NCT01827904
Title ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors
Official title A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects
Lead sponsor InSightec, Industry
Status Completed
Study type Interventional
Conditions Essential Tremor
Intervention type Device
Interventions Transcranial ExAblate, Sham Transcranial ExAblate
Enrollment 76
Start date May 1, 2013
Primary completion Feb 24, 2021
Completion Feb 24, 2021
First posted Apr 10, 2013
Last update posted Aug 27, 2024
Countries Canada, Japan, South Korea, United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies